Brief: Argent Biopharma Seeks Trading Halt
28/06/2024 02:21
June 28 (Reuters) - Argent BioPharma Ltd RGT.AX :
* SEEKS TRADING HALT PENDING RELEASE OF AN ANNOUNCEMENT
REGARDING
A CAPITAL RAISING
Source text for Eikon: ID:nASX8wjllM
Further company coverage: RGT.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Argent BioPharma
See all newsBrief: Argent Biopharma Enters Long Term Aquiol Licensing And Supply Agreement
Brief: Argent Biopharma Secures A$11M Financing Facility To Complete Strategic Acquisition
Brief: Argent Is Growing Through M&A Projected Merged Company Value Of $100M In Ac8 Asset Acquisition
Australia's Argent BioPharma set for best day in a year on AusCann deal
Brief: Argent Biopharma To Acquire Core Operating Assets And IP Portfolio Of Auscann Group